These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1381755)

  • 1. Loss of epithelial L1 expression is associated with cellular invasion of oral squamous cell carcinomas.
    Heyden A; Thrane PS; Brandtzaeg P
    J Oral Pathol Med; 1992 Aug; 21(7):330-5. PubMed ID: 1381755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratins as epithelial differentiation markers in premalignant and malignant oral lesions.
    Heyden A; Huitfeldt HS; Koppang HS; Thrane PS; Bryne M; Brandtzaeg P
    J Oral Pathol Med; 1992 Jan; 21(1):7-11. PubMed ID: 1375644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The L1 antigen and squamous metaplasia in the bladder.
    Tungekar MF; Heryet A; Gatter KC
    Histopathology; 1991 Sep; 19(3):245-50. PubMed ID: 1717359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Human leukocyte antigen-DR expression and transcription in oral squamous cell carcinomas].
    Li L; Zhang S; Tong M
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Feb; 21(1):48-51. PubMed ID: 12674623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial dendritic cells in pathological human oral tissues.
    Pitigala-Arachchi A; Crane IJ; Scully C; Prime SS
    J Oral Pathol Med; 1989 Jan; 18(1):11-6. PubMed ID: 2473203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of expression of blood group antigen H is associated with cellular invasion and spread of oral squamous cell carcinomas.
    Bryne M; Thrane PS; Dabelsteen E
    Cancer; 1991 Feb; 67(3):613-8. PubMed ID: 1985757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DR antigen expression in squamous epithelial dysplasia and squamous cell carcinoma of the esophagus: an immunohistochemical study.
    Sumiyoshi K; Kuwano H; Watanabe M; Kitamura M; Toh Y; Sugimachi K
    Oncol Rep; 1999; 6(2):301-6. PubMed ID: 10022993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of epithelial blood group substance A in oral carcinomas.
    Dabelsteen E; Pindborg JJ
    Acta Pathol Microbiol Scand A; 1973 Jul; 81(4):435-44. PubMed ID: 4130926
    [No Abstract]   [Full Text] [Related]  

  • 9. The expression of cell surface MHC class I heavy and light chain molecules in pre-malignant and malignant lesions of the oral mucosa.
    Prime SS; Pitigala-Arachchi A; Crane IJ; Rosser TJ; Scully C
    Histopathology; 1987 Jan; 11(1):81-91. PubMed ID: 3549515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokeratin alterations as diagnostic and prognostic markers of oral and pharyngeal carcinomas. A prospective study.
    Depondt J; Shabana AH; Sawaf H; Gehanno P; Forest N
    Eur J Oral Sci; 1999 Dec; 107(6):442-54. PubMed ID: 10625103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local immune response to tumor invasion in esophageal squamous cell carcinoma. The expression of human leukocyte antigen-DR and lymphocyte infiltration.
    Sadanaga N; Kuwano H; Watanabe M; Maekawa S; Mori M; Sugimachi K
    Cancer; 1994 Jul; 74(2):586-91. PubMed ID: 8033037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous PAGE, immunoblotting, and immunohistochemical analysis of differentiation associated keratins in lesions of the oral mucosa.
    Itoiz ME; Larcher F; Lanfranchi HE; Diaz J; Klein-Szanto AJ; Conti CJ
    Acta Odontol Latinoam; 1993; 7(2):13-22. PubMed ID: 11885243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical analysis of dendritic cell in oral squamous cell carcinoma].
    Wang ZY; Li SW; Hu QG; Tian WD
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Apr; 22(2):103-5, 131. PubMed ID: 15190787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunolocalization of desmoglein and intermediate filaments in human oral squamous cell carcinomas.
    Imai K; Kumagai S; Nakagawa K; Yamamoto E; Nakanishi I; Okada Y
    Head Neck; 1995; 17(3):204-12. PubMed ID: 7540167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodetection of keratin proteins in oral epithelial neoplasms.
    Narayana N; Gadewar D
    Indian J Dent Res; 1992; 3(3):68-75. PubMed ID: 1285339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of CD44 variant 6 and its metastatic potential in squamous cell carcinoma of the oral cavity].
    Kunishi M; Kayada Y; Tsumura M; Yoshiga K; Takada K
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):1045-8. PubMed ID: 8687219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression of differentiation-specific keratins in oral epithelial dysplasia and squamous cell carcinoma.
    Bloor BK; Seddon SV; Morgan PR
    Oral Oncol; 2001 Apr; 37(3):251-61. PubMed ID: 11287279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-surface expression of complement restriction factors and sialyl Lewis antigens in oral carcinoma: relevance to chemo-immunotherapy.
    Ravindranath NM; Nishimoto K; Chu K; Shuler C
    Anticancer Res; 2000; 20(1A):21-6. PubMed ID: 10769630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferating cell nuclear antigen (PCNA) and p53 in epithelial dysplasia and squamous cell carcinoma of oral mucosa--a marker for poor tumor differentiation, increasing nuclear atypia and invasiveness?
    Lan HA; Zain RB; Saitoh M; Muramatsu Y; Shrestha P; Mori M
    Anticancer Res; 1996; 16(5B):3059-65. PubMed ID: 8920767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in expression of terminal differentiation markers of keratinocytes during oral carcinogenesis.
    Kannan S; Balaram P; Chandran GJ; Pillai MR; Mathew B; Nalinakumari KR; Nair MK
    Pathobiology; 1994; 62(3):127-33. PubMed ID: 7524529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.